Adialante
Adialante is listed by Robinhood as a YCX26 company in the Robinhood Ventures Fund II portfolio. Robinhood reports the fund's exposure may be direct or through one or more SPVs.
Healthcare
Current Valuation
Private
PRIVATE
IPO Outlookprivate
Is Adialante going public?
No. Adialante is private and has not filed to go public. There is no S-1 on file.
What is Adialante's valuation in 2026?
No confirmed valuation is on record for Adialante. The roster shows funding and investors where they are public; it does not estimate a mark.
Has Adialante filed an S-1?
No public S-1 is on file for Adialante.
Is Adialante publicly traded — can you buy Adialante stock?
No. Adialante is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Adialante on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Fundraising Status
Company-specific financing undisclosed — Robinhood’s RVII portfolio disclosure reports fund exposure, not a company financing amount, round, or date. YC standard program backing is separately attributed below.
private
Talent Signal
No public careers page or job board could be found for Adialante as of 2026-09-14. That itself is a datapoint: no open external hiring surface.
Checked the company site and major hosted job boards. Re-checked monthly.
Y CombinatorYCX26Robinhood Ventures Fund II
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of recent date. Refreshed quarterly.